EUVIMEDEUVIMED entdecken
Crossref

LAVR-289, an Acyclo-Nucleoside Phosphonate, Has Broad-Spectrum Activity against Herpesviruses

Sandrine Kappler-Gratias, Charlotte Quentin-Froignant iD, Elie Marcheteau, José Fernandez, David Boutolleau, Virginie Garcia, Vincent Roy, Luigi A Agrofoglio, Franck Gallardo iD

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.5c00171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Sandrine Kappler-Gratias und 8 weiteren Autor:innen. Beteiligte Einrichtung: NeoVirTech SAS, Toulouse 31106, France. Hauptthemen laut MEDLINE: Antiviral Agents, Herpesviridae, Organophosphonates, Acyclovir. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, European Regional Development Fund, Universit? d'Orl?ans.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human herpesviruses are large dsDNA viruses that primarily cause opportunistic infections in healthy adults but can trigger life-threatening infections in immunocompromised patients. Previously, antivirals have been developed against a variety of herpesviruses; these include acyclovir for herpes simplex viruses (HSV1 and 2) and ganciclovir and letermovir for human cytomegalovirus (hCMV). However, broad-spectrum inhibitors of herpesvirus infections are still lacking. Here we report the efficacy of LAVR-289, a new acyclic nucleoside analogue, on a broad range of herpesviruses of human and animal origin. LAVR-289 displays nanomolar efficacy in vitro, is active on viral strains resistant to gold-standard antivirals and is efficacious ex vivo on reconstituted human skin infected with HSV1. In addition, the activity of LAVR-289 against poxviruses and adenoviruses is an indication of its potential for the management of opportunistic virus infections in immunocompromised patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHerpesviridaeOrganophosphonatesAcyclovirNucleosidesHumansAnimalsHerpesviridae InfectionsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

LAVR-289acyclonucleoside phosphonatebroad-spectrum antiviralherpesviruses

Substanzen

Antiviral AgentsOrganophosphonatesAcyclovirNucleosides

Autor:innen und Institutionen

  • NeoVirTech SAS, Toulouse 31106, France.
  • Sorbonne Université, INSERM U1136, Pierre Louis Institute of Epidemiology and Public Health (IPLESP), THERAVIR team, Paris 75651, France.
  • AP-HP. Sorbonne Université, National Reference Center for Herpesviruses (associated laboratory), Virology Department, Pitié-Salpêtrière Hospital, Paris 75651, France.
  • Unité Mixte de Recherche Institut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches e…
  • Institute of Organic and Analytical Chemistry (ICOA UMR 7311), University of Orleans, CNRS, F-45067 Orléans, France.

ORCID-Profile: Charlotte Quentin-Froignant, Franck Gallardo

Förderung

  • Agence Nationale de la Recherche
  • European Regional Development Fund
  • Universit? d'Orl?ans
  • Centre National de la Recherche Scientifique
  • French Defense Innovation Agency
  • Region Centre Val de Loire

Zitieren

APA

Kappler-Gratias, S., Quentin-Froignant, C., Marcheteau, E., Fernandez, J., Boutolleau, D., Garcia, V., Roy, V., Agrofoglio, L. A., & Gallardo, F. (2025). LAVR-289, an Acyclo-Nucleoside Phosphonate, Has Broad-Spectrum Activity against Herpesviruses. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00171

Vancouver

Kappler-Gratias S, Quentin-Froignant C, Marcheteau E, Fernandez J, Boutolleau D, Garcia V, et al. LAVR-289, an Acyclo-Nucleoside Phosphonate, Has Broad-Spectrum Activity against Herpesviruses. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00171

BibTeX
@article{KapplerGratias2025,
  author = {Kappler-Gratias, Sandrine and Quentin-Froignant, Charlotte and Marcheteau, Elie and Fernandez, José and Boutolleau, David and Garcia, Virginie and Roy, Vincent and Agrofoglio, Luigi A and Gallardo, Franck},
  title = {LAVR-289, an Acyclo-Nucleoside Phosphonate, Has Broad-Spectrum Activity against Herpesviruses},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.5c00171}
}
Kostenlos starten →